Dr David M Schaffzin, MD in Langhorne, PA - Medicare Colon & Rectal Surgery

Dr David M Schaffzin, MD is a medicare enrolled "Colon & Rectal Surgery" physician in Langhorne, Pennsylvania. His current practice location is 1203 Langhorne Newtown Rd, St. Clare Medical Bldg, Suite 130, Langhorne, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (215) 741-4910.

Dr David M Schaffzin is licensed to practice in Pennsylvania (license number MD069534L) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1275582587.

Contact Information

	Dr David M Schaffzin, MD
	1203 Langhorne Newtown Rd, St. Clare Medical Bldg, Suite 130, Langhorne, PA 19047-1209
	(215) 741-4910
	(215) 741-4394

Physician's Profile

Full Name	Dr David M Schaffzin
Gender	Male
Speciality	Colon & Rectal Surgery
Location	1203 Langhorne Newtown Rd, Langhorne, Pennsylvania
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1275582587
Provider Enumeration Date: 05/06/2006
Last Update Date: 12/29/2009

Medicare PECOS Information:

PECOS PAC ID: 7618937301
Enrollment ID: I20100121000300

Medical Identifiers

Medical identifiers for Dr David M Schaffzin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275582587	NPI	-	NPPES
0051179	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	25MA07746400 (New Jersey)	Secondary
208C00000X	Colon & Rectal Surgery	MD069534L (Pennsylvania)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr David M Schaffzin allows following entities to bill medicare on his behalf.

Entity Name	Center For Colon And Rectal Health, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1831338466 PECOS PAC ID: 5991852907 Enrollment ID: O20090408000650

News Archive

Differences between benign and cancerous moles

Research into a cancer that is on the rise in the UK is to be presented at the University of Leicester.

AMRI announces acquisition of Hyaluron

AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.

Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy designation to PKC412 (midostaurin). PKC412 (midostaurin) is an investigational treatment for adults with newly-diagnosed AML who are FLT3 mutation-positive, as detected by an FDA-approved test, and who are eligible to receive standard induction and consolidation chemotherapy.

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.

Medical researchers take the next step in personalized medicine

Prescription drugs and their dosages may be standardized, but not every patient reacts to a medicine in the same way. The personal genetic characteristics of individuals and populations can explain why a specific prescription successfully treats one patient and not another, so medical researchers are adopting the new approach called "personalized medicine" and a Tel Aviv University lab is leading the way.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David M Schaffzin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David M Schaffzin, MD 1203 Langhorne Newtown Rd, St. Clare Medical Bldg, Suite 130, Langhorne, PA 19047-1209 Ph: (215) 741-4910	Dr David M Schaffzin, MD 1203 Langhorne Newtown Rd, St. Clare Medical Bldg, Suite 130, Langhorne, PA 19047-1209 Ph: (215) 741-4910

News Archive

Differences between benign and cancerous moles

Research into a cancer that is on the rise in the UK is to be presented at the University of Leicester.

Dr David M Schaffzin, MD - Medicare Colon & Rectal Surgery in Langhorne, PA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Differences between benign and cancerous moles

AMRI announces acquisition of Hyaluron

Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Medical researchers take the next step in personalized medicine

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Differences between benign and cancerous moles

AMRI announces acquisition of Hyaluron

Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Medical researchers take the next step in personalized medicine